Vident Investment Advisory’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Vident Investment Advisory’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,912	Closed	-$232K	–	1368
2023 Q1	$232K	Buy	+15,912	New	+$225K	0.01%	1046

Vident Investment Advisory's AMYT Position: Q2 2023 in Review

Vident Investment Advisory sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 15,912 shares — an estimated $232K sold.

Vident Investment Advisory first reported a position in AMYT in Q1 2023 and held it in 1 quarter. The position peaked at $232K in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Vident Investment Advisory reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Vident Investment Advisory sold 15,912 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $232K.
Vident Investment Advisory first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2023 and held it in 1 quarter.
Vident Investment Advisory's Amryt Pharma plc American Depositary Shares position peaked at $232K in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.